• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

世界卫生组织 2022 年肾脏肿瘤分类：哪些是相关的？病理学家的更新和未来的新进展。

WHO 2022 Classification of Kidney Tumors: what is relevant? An update and future novelties for the pathologist.

机构信息

Department of Diagnostic and Public Health, Section of Pathology, University of Verona, Italy.

Department of Pathology, Pederzoli Hospital, Peschiera, Italy.

出版信息

Pathologica. 2022 Feb;115(1):23-31. doi: 10.32074/1591-951X-814. Epub 2023 Jan 16.

DOI:10.32074/1591-951X-814
PMID:36645397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10342215/
Abstract

Classification systems reflect our technical abilities in the investigation of tumors and our current theories on tumor development. Herein, by providing a historical perspective on the evolution of classifying renal tumors, we assess the current WHO classification highlighting the novelties and the implications of these changes in daily clinical practice.

摘要

分类系统反映了我们在肿瘤研究方面的技术能力和目前对肿瘤发展的理论认识。本文通过回顾肾肿瘤分类的演变历史，评估现行的 WHO 分类，重点介绍这些变化的新颖之处及其对日常临床实践的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/840e/10342215/c743755b7978/pathol-2023-01-23-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/840e/10342215/4d50cfca7411/pathol-2023-01-23-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/840e/10342215/900db64f6413/pathol-2023-01-23-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/840e/10342215/7b05d857957d/pathol-2023-01-23-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/840e/10342215/208bead0da6e/pathol-2023-01-23-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/840e/10342215/c743755b7978/pathol-2023-01-23-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/840e/10342215/4d50cfca7411/pathol-2023-01-23-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/840e/10342215/900db64f6413/pathol-2023-01-23-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/840e/10342215/7b05d857957d/pathol-2023-01-23-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/840e/10342215/208bead0da6e/pathol-2023-01-23-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/840e/10342215/c743755b7978/pathol-2023-01-23-g005.jpg

相似文献

1
WHO 2022 Classification of Kidney Tumors: what is relevant? An update and future novelties for the pathologist.世界卫生组织 2022 年肾脏肿瘤分类：哪些是相关的？病理学家的更新和未来的新进展。
Pathologica. 2022 Feb;115(1):23-31. doi: 10.32074/1591-951X-814. Epub 2023 Jan 16.
2
[WHO classification 2016 and first S3 guidelines on renal cell cancer: What is important for the practice?].[《2016年世界卫生组织分类及肾细胞癌首个S3指南：对临床实践而言什么是重要的？》]
Pathologe. 2016 Mar;37(2):127-33. doi: 10.1007/s00292-016-0144-1.
3
European Association of Urology Guidelines Panel on Renal Cell Carcinoma Update on the New World Health Organization Classification of Kidney Tumours 2022: The Urologist's Point of View.欧洲泌尿外科协会肾细胞癌指南小组关于《2022年世界卫生组织肾脏肿瘤分类》的更新：泌尿外科医生的观点。
Eur Urol. 2023 Feb;83(2):97-100. doi: 10.1016/j.eururo.2022.11.001. Epub 2022 Nov 23.
4
Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classification.2022年世界卫生组织肾细胞癌分类的临床病理意义
Cancer Treat Rev. 2023 May;116:102558. doi: 10.1016/j.ctrv.2023.102558. Epub 2023 Apr 9.
5
Advances in molecular classification of renal neoplasms.肾肿瘤分子分类的进展
Histol Histopathol. 2006 Mar;21(3):325-39. doi: 10.14670/HH-21.325.
6
Pathology of renal cell carcinoma: an update.肾细胞癌的病理学：最新进展
Anal Quant Cytopathol Histpathol. 2013 Apr;35(2):61-76.
7
[Pathology of kidney tumors: introduction of the 2004 WHO classification].[肾肿瘤病理学：2004年世界卫生组织分类介绍]
Zhonghua Bing Li Xue Za Zhi. 2006 Sep;35(9):517-9.
8
Morphologic, Molecular, and Taxonomic Evolution of Renal Cell Carcinoma: A Conceptual Perspective With Emphasis on Updates to the 2016 World Health Organization Classification.肾细胞癌的形态学、分子学及分类学演变：基于2016年世界卫生组织分类更新的概念性观点
Arch Pathol Lab Med. 2016 Oct;140(10):1026-37. doi: 10.5858/arpa.2016-0218-RA.
9
Current trends in the molecular classification of renal neoplasms.肾肿瘤分子分类的当前趋势
ScientificWorldJournal. 2006 Dec 15;6:2505-18. doi: 10.1100/tsw.2006.390.
10
[Renal cell carcinoma diagnosis and prognosis within the context of the WHO classification 2016].[2016年世界卫生组织分类背景下的肾细胞癌诊断与预后]
Urologe A. 2019 Sep;58(9):1057-1065. doi: 10.1007/s00120-019-0952-z.

引用本文的文献

1
Non-clear cell renal cell carcinoma narrative review: where we are in 2024.非透明细胞肾细胞癌叙述性综述：2024年我们所处的位置
Transl Cancer Res. 2024 Nov 30;13(11):6403-6412. doi: 10.21037/tcr-24-737. Epub 2024 Nov 12.
2
TFE3-Rearranged Tumors of the Kidney: An Emerging Conundrum.肾TFE3重排肿瘤：一个新出现的难题。
Cancers (Basel). 2024 Oct 4;16(19):3396. doi: 10.3390/cancers16193396.
3
Contemporary Management of Renal Cell Carcinoma: A Review for General Practitioners in Oncology.当代肾癌的治疗管理：普通肿瘤科医师综述。

本文引用的文献

1
TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms.TFE3 和 TFEB 重排的肾细胞癌：一个免疫组织化学panel 来与常见的肾细胞肿瘤相鉴别。
Virchows Arch. 2022 Dec;481(6):877-891. doi: 10.1007/s00428-022-03380-x. Epub 2022 Aug 18.
2
Translocation carcinomas of the kidney.肾转移癌。
Genes Chromosomes Cancer. 2022 May;61(5):219-227. doi: 10.1002/gcc.23007. Epub 2021 Nov 3.
3
Low-grade oncocytic renal tumor (LOT): mutations in mTOR pathway genes and low expression of FOXI1.
Curr Oncol. 2024 Aug 22;31(8):4795-4817. doi: 10.3390/curroncol31080359.
4
Diagnostic Biomarkers in Renal Cell Tumors According to the Latest WHO Classification: A Focus on Selected New Entities.根据世界卫生组织最新分类的肾细胞肿瘤诊断生物标志物：聚焦选定的新实体
Cancers (Basel). 2024 May 13;16(10):1856. doi: 10.3390/cancers16101856.
5
Tumor-to-Tumor Metastasis of Lung Cancer to Kidney Cancer: A Review of the Literature and Our Experience.肺癌至肾癌的肿瘤间转移：文献综述及我们的经验
Diagnostics (Basel). 2024 Mar 5;14(5):553. doi: 10.3390/diagnostics14050553.
6
Safety and Diagnostic Efficacy of Image-Guided Biopsy of Small Renal Masses.影像引导下小肾肿块活检的安全性和诊断效能
Cancers (Basel). 2024 Feb 19;16(4):835. doi: 10.3390/cancers16040835.
7
Multimodality imaging of Xp11.2 translocation/TFE3 gene fusion associated with renal cell carcinoma: a case report.与肾细胞癌相关的Xp11.2易位/TFE3基因融合的多模态成像：病例报告
Front Med (Lausanne). 2023 Sep 19;10:1266630. doi: 10.3389/fmed.2023.1266630. eCollection 2023.
8
The Transition From Localized to Metastatic: A Case Report of Adult TFE3-Positive Xp11.2 Translocation Renal Cell Carcinoma.从局限性到转移性的转变：一例成人TFE3阳性Xp11.2易位性肾细胞癌病例报告
Cureus. 2023 Aug 12;15(8):e43378. doi: 10.7759/cureus.43378. eCollection 2023 Aug.
9
Renal cell carcinoma not otherwise specified: A case report in Indonesia.未另行规定的肾细胞癌：印度尼西亚的一例病例报告。
Urol Case Rep. 2023 Aug 14;50:102527. doi: 10.1016/j.eucr.2023.102527. eCollection 2023 Sep.
10
Cystic Clear Cell Renal Cell Carcinoma: A Morphological and Molecular Reappraisal.囊性透明细胞肾细胞癌：形态学与分子学再评估
Cancers (Basel). 2023 Jun 26;15(13):3352. doi: 10.3390/cancers15133352.
低级别嗜酸细胞瘤性肾肿瘤（LOT）：mTOR 通路基因的突变和 FOXI1 的低表达。
Mod Pathol. 2022 Mar;35(3):352-360. doi: 10.1038/s41379-021-00906-7. Epub 2021 Sep 16.
4
Diagnostic utility of one-stop fusion gene panel to detect TFE3/TFEB gene rearrangement and amplification in renal cell carcinomas.一站式融合基因 panel 在检测肾细胞癌中 TFE3/TFEB 基因重排和扩增的诊断效用。
Mod Pathol. 2021 Nov;34(11):2055-2063. doi: 10.1038/s41379-021-00858-y. Epub 2021 Jun 19.
5
Cathepsin K: A Novel Diagnostic and Predictive Biomarker for Renal Tumors.组织蛋白酶K：一种用于肾肿瘤的新型诊断和预测生物标志物。
Cancers (Basel). 2021 May 18;13(10):2441. doi: 10.3390/cancers13102441.
6
TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study.TSC 缺失是嗜酸性实体和囊性肾细胞癌的克隆事件：一项多区域肿瘤取样研究。
Mod Pathol. 2022 Mar;35(3):376-385. doi: 10.1038/s41379-021-00816-8. Epub 2021 May 14.
7
Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma.琥珀酸脱氢酶缺陷型肾细胞癌的全面分子特征分析及治疗反应
Clin Cancer Res. 2021 May 15;27(10):2910-2919. doi: 10.1158/1078-0432.CCR-20-4367. Epub 2021 Mar 3.
8
Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.新型、新兴和暂定的肾脏实体：泌尿生殖系统病理学学会（GUPS）关于肾脏肿瘤的更新。
Mod Pathol. 2021 Jun;34(6):1167-1184. doi: 10.1038/s41379-021-00737-6. Epub 2021 Feb 1.
9
Clinicopathological and molecular characterisation of papillary renal neoplasm with reverse polarity and its renal papillary adenoma analogue.具有反向极性的乳头状肾肿瘤及其肾乳头状腺瘤类似物的临床病理和分子特征。
Histopathology. 2021 Jun;78(7):1019-1031. doi: 10.1111/his.14320. Epub 2021 Apr 10.
10
Contributions of genetics to the evolution of the diagnostic classification of renal cell neoplasia: a personal perspective.遗传学对肾细胞肿瘤诊断分类演变的贡献：个人观点。
Pathology. 2021 Jan;53(1):96-100. doi: 10.1016/j.pathol.2020.10.004. Epub 2020 Nov 21.